Multiple Myeloma Research Foundation - Accelerating the development of next generation #myeloma treatments to extend patients' lives, and lead to a cure.
Investigators at @DanaFarber developed a new risk prediction model for smoldering multiple myeloma called PANGEA-SMM, which outperformed existing models in a recent study published in @NatureMedicine: bit.ly/49WHMcA
Mariska Hargitay honors her father’s legacy by sharing his multiple myeloma story as part of BMS’s new “Investigating Myeloma” awareness campaign.
In @CUREtoday, she highlights awareness ongoing CELMoD research advancing treatment.
Read more: bit.ly/4gcr4tC
Know an early-career myeloma researcher who should apply for the 2026 MMRF Scholars Program or the MMRF Research Fellowship Program?
Tag them!
Learn more: themmrf.org/for-researchers/…
About 1 in 5 myeloma patients have high-risk disease, one of the greatest unmet needs in the field. The MMRF's Horizon Two clinical trial aims to identify the best treatments for high-risk, newly diagnosed patients.
Learn More: themmrf.org/mmrf-blogs/first…
Every mile, every story, every rider, all in pursuit of a cure for myeloma. This is Road to Victories.
Join us for an unforgettable ride in the Blue Ridge Mountains from 9/28 to 10/3, on a course between Greenville, SC and Asheville, NC.
Ready to ride? endurance.themmrf.org/r2v202…
The estimated 20% of myeloma patients with high-risk disease relapse quickly and cycle through standard therapies faster. The MMRF's Horizon Two clinical trial aims to identify the best treatments for high-risk, newly diagnosed patients.
Learn more: themmrf.org/mmrf-blogs/first…
We were honored to share a case study on Virtual Lab, the largest open-access dataset in multiple myeloma, at @FoGenomics in Boston. The platform demonstrates the MMRF’s commitment to make high-quality myeloma data widely accessible to drive progress for patients.
Meet Kevin Ballantine, the Spirit of Hope recipient at the MMRF Walk in Charlotte this weekend. Diagnosed with myeloma in December 2024, Kevin wore a different sports jersey to each of his 40 treatments. Join us for a walk this fall: walk.themmrf.org
New research presented at #ASCO2026 highlighted:
1️⃣ When it is safe to stop treatment
2️⃣ The value of MRD testing
3️⃣ The importance of treatment sequencing
Learn more in our recap blog: themmrf.org/mmrf-blogs/asco-…
Road to Victories is back! From Sept 28 to Oct 3, we're riding the Blue Ridge Mountains between Greenville, SC and Asheville, NC to fuel lifesaving myeloma research. Ready to ride? Apply today: endurance.themmrf.org/r2v202…
During the first two days of ASCO 2026, studies have provided new insights into some of the most common questions we hear from myeloma patients. Here are our takeaways: bit.ly/4nWcF6B
New treatment options are being investigated for high-risk smoldering multiple myeloma patients. Director of Educational Programs Chris Peña shares takeaways from a promising new study that evaluated using the bispecific elranatamab as an earlier line treatment. #ASCO2026
Every patient deserves to feel informed, supported, and empowered on their myeloma journey. Our 2025 Donor Impact Report shows how your support is making that possible. See the full impact: themmrf.org/mmrf-blogs/mmrf-…
The first patient has enrolled in Horizon Two, an MMRF-led clinical trial identifying the best treatments for high-risk, newly diagnosed myeloma patients. Its innovative adaptive platform design allows researchers to deliver answers faster. Learn more: themmrf.org/mmrf-blogs/first…
What an incredible spring season! Team for Cures athletes participated in 10 endurance races, and they raised more than $700,000 to further the MMRF's mission of accelerating a cure for multiple myeloma. Thank you to every Team for Cures. Want to join us? endurance.themmrf.org/
What does it take to bring a new myeloma treatment from the lab to patients? This @WebMD article breaks down the FDA approval journey and features MMRF CMO @HJChoMDPhD1. Read more: webmd.com/cancer/multiple-my…
Living with relapsed or refractory myeloma? Join our free webinar on how immunotherapy is transforming treatment. Learn about current and emerging therapies, what they mean for your care, and new clinical trials.
Register: bit.ly/4eUe63g